- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: CCL13
Gene name: chemokine (C-C motif) ligand 13
HGNC ID: 10611
Synonyms: MCP-4, NCC-1, SCYL1, CKb10, MGC17134
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | CCL11 | 1 hits |
| 2 | CCL18 | 1 hits |
| 3 | CCL2 | 1 hits |
| 4 | CCL26 | 1 hits |
| 5 | CD209 | 1 hits |
| 6 | CLEC11A | 1 hits |
| 7 | CXCR4 | 1 hits |
| 8 | MRC1 | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 21826115 | We found an altered chemokine profile tracking with disease progression, with significant elevations of five chemokines (eotaxin-3, MIP-1β, eotaxin, MCP-1 and MCP-4) while three (eotaxin-3, MIP-1β and eotaxin) showed significant linear increases across advancing disease stages. |
| 2 | 21826115 | Here we saw that chemokine levels (MCP-1 and eotaxin) correlated with clinical scores. |
| 3 | 23710834 | Beyond the impact on survival in M2, RAPA reduced CXCR4, CD206 and CD209 expression and stem cell growth factor-β, CCL18 and CCL13 release. |
| 4 | 23710834 | In contrast, in M1 RAPA increased CD86 and CCR7 expression and IL-6, tumour necrosis factor-α and IL-1β release but reduced CD206 and CD209 expression and IL-10, vascular endothelial growth factor and CCL18 release. |